Quarterly report pursuant to Section 13 or 15(d)

Selected Balance Sheet Information

v3.22.1
Selected Balance Sheet Information
3 Months Ended
Mar. 31, 2022
Selected Balance Sheet Information  
Selected Balance Sheet Information

5. Selected Balance Sheet Information

Prepaid expenses and other current assets (in thousands)

March 31, 

December 31, 

    

2022

    

2021

Receivable from prior owner

$

1,594

$

Prepaid insurances

557

803

Prepaid clinical research organizations

266

458

Prepaid consulting, subscriptions and other expenses

217

272

VAT receivable

127

Prepaid manufacturing expenses

 

102

 

Total

$

2,863

$

1,533

Prepaid clinical research organizations (CROs) expense is classified as a current asset. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services. Receivable from prior VCN owner includes amounts due related to research and development tax rebates, VAT and corporate taxes.

5. Selected Balance Sheet Information – (continued)

Property and equipment, net (in thousands)

    

March 31, 

December 31, 

2022

    

2021

Computers and office equipment

$

1,348

$

827

Leasehold improvements

 

94

 

94

Software

 

15

 

11

 

1,456

 

932

Less: accumulated depreciation and amortization

 

(1,154)

 

(831)

Total

$

302

$

101

Accrued expenses (in thousands)

    

March 31, 

December 31, 

2022

    

2021

Accrued clinical consulting services

$

1,008

$

696

Accrued vendor payments

 

305

 

1,028

Accrued manufacturing costs

126

204

Vat payable

91

Other accrued expenses

 

5

 

Total

$

1,535

$

1,928

Accrued employee benefits (in thousands)

    

March 31, 

December 31, 

2022

    

2021

Accrued bonus expense

$

225

$

886

Accrued vacation expense

115

92

Accrued compensation expense

 

83

 

Total

$

423

$

978